C1R and neoplasm: C1R targets bearing Q115E HLA-A2 were able to induce more of the fully phosphorylated p23 form 29 of the TCR ζ chain in anti-tumour and anti-viral CTL compared to similar targets bearing wild-type HLA-A2 standardized for surface antigen expression levels (Fig. 6A, B).